Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma
Mo, Dun-Chang, Huang, Jian-Feng, Luo, Peng-Hui, Chen, Long, Huang, Shang-Xiao
Published in The lancet oncology (01.01.2023)
Published in The lancet oncology (01.01.2023)
Get full text
Journal Article
Letter: sequential or combinated systemic treatment for unresectable hepatocellular carcinoma
Mo, Dun‐Chang, Luo, Peng‐Hui, Huang, Jian‐Feng
Published in Alimentary pharmacology & therapeutics (01.09.2020)
Published in Alimentary pharmacology & therapeutics (01.09.2020)
Get full text
Journal Article
Radiotherapy for children and adolescents with early-stage classical Hodgkin lymphoma
Mo, Dun-Chang, Huang, Jian-Feng, Luo, Peng-Hui, Liang, Xiu-Juan, Wang, Han-Lei
Published in The lancet oncology (01.06.2023)
Published in The lancet oncology (01.06.2023)
Get full text
Journal Article
Severe and fatal adverse events of immune checkpoint inhibitor combination therapy in patients with metastatic renal cell carcinoma: a systematic review and meta-analysis
Feng, Yao-Ning, Xie, Guang-Yu, Xiao, Li, Mo, Dun-Chang, Huang, Jian-Feng, Luo, Peng-Hui, Liang, Xiu-Juan
Published in Frontiers in immunology (19.06.2023)
Published in Frontiers in immunology (19.06.2023)
Get full text
Journal Article
Low-Dose Immunotherapy Plus Triple Metronomic Chemotherapy for Head and Neck Cancer
Mo, Dun-Chang, Huang, Jian-Feng, Luo, Peng-Hui
Published in Journal of clinical oncology (20.03.2023)
Published in Journal of clinical oncology (20.03.2023)
Get full text
Journal Article
Combination therapy with immune checkpoint inhibitors in recurrent or metastatic squamous cell carcinoma of the head and neck: A meta-analysis
Chen, Long, Mo, Dun-Chang, Hu, Min, He, Wei, Yang, Qiang-Wei, Tang, Jun
Published in International immunopharmacology (01.06.2023)
Published in International immunopharmacology (01.06.2023)
Get full text
Journal Article
Safety and efficacy of pembrolizumab plus lenvatinib versus pembrolizumab and lenvatinib monotherapies in cancers: A systematic review
Mo, Dun-Chang, Luo, Peng-Hui, Huang, Shang-Xiao, Wang, Han-Lei, Huang, Jian-Feng
Published in International immunopharmacology (01.02.2021)
Published in International immunopharmacology (01.02.2021)
Get full text
Journal Article
Adjuvant radiotherapy omission in early breast cancer: the PROSPECT trial
Mo, Dun-Chang, Huang, Jian-Feng, Luo, Peng-Hui, Wang, Han-Lei, Liang, Xiu-Juan
Published in The Lancet (British edition) (10.08.2024)
Published in The Lancet (British edition) (10.08.2024)
Get full text
Journal Article
Predicted Value of PD-L1 for Patients With Cervical Cancer Treated With Pembrolizumab
Luo, Peng-Hui, Mo, Dun-Chang, Wang, Han-Lei, Liang, Xiu-Juan, Huang, Jian-Feng
Published in Journal of clinical oncology (01.05.2024)
Published in Journal of clinical oncology (01.05.2024)
Get full text
Journal Article
Daratumumab, Bortezomib, and Dexamethasone for Previously Treated Multiple Myeloma
Huang, Shang-Xiao, Luo, Peng-Hui, Wang, Han-Lei, Mo, Dun-Chang, Huang, Jian-Feng
Published in Journal of clinical oncology (10.05.2023)
Published in Journal of clinical oncology (10.05.2023)
Get full text
Journal Article
Efficacy of immune checkpoint inhibitor as maintenance therapy for advanced or metastatic cancers: A meta-analysis of randomized controlled trials
Mo, Dun-Chang, Huang, Jian-Feng, Luo, Peng-Hui, Huang, Shang-Xiao, Wang, Han-Lei
Published in Medicine (Baltimore) (23.09.2022)
Published in Medicine (Baltimore) (23.09.2022)
Get full text
Journal Article